Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soininen

Showing results (361-370 of 1,209) with videos related to

Pageof 121
Sort By:
Neuroreport|June 19, 1995
Hippocampal atrophy, acute THA treatment and memory in Alzheimer's diseaseP Riekkinen, H Soininen, E L Helkala, et al.
Mechanisms of Development|November 1, 1992
The mouse Enhancer trap locus 1 (Etl-1): a novel mammalian gene related to Drosophila and yeast transcriptional regulator genesR Soininen, M Schoor, U Henseling, et al.
Neuroscience|January 1, 1995
Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's diseaseO Heinonen, H Soininen, H Sorvari, et al.
Journal of Neurology|April 29, 2008
Genetic study between SIRT1, PPARD, PGC-1alpha genes and Alzheimer's diseaseS Helisalmi, S Vepsäläinen, M Hiltunen, et al.
Toxicology Letters|September 19, 2015
Human placental cell and tissue uptake of doxorubicin and its liposomal formulationsSuvi K Soininen, Jenni K Repo, Vesa Karttunen, et al.
Neuroscience|August 1, 1992
Slowing of electroencephalogram and choline acetyltransferase activity in post mortem frontal cortex in definite Alzheimer's diseaseH Soininen, K J Reinikainen, J Partanen, et al.
The European Journal of Neuroscience|April 14, 2004
Visual presentation of novel objects and new spatial arrangements of objects differentially activates the medial temporal lobe subareas in humansMaija Pihlajamäki, Heikki Tanila, Mervi Könönen, et al.
Neuroscience Letters|May 6, 2008
Increased expression of Abeta degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathologySaila Vepsäläinen, Mikko Hiltunen, Seppo Helisalmi, et al.
Diabetes Care|January 24, 2013
History of medically treated diabetes and risk of Alzheimer disease in a nationwide case-control studyAnna-Maija Tolppanen, Piia Lavikainen, Alina Solomon, et al.
Neuroscience Letters|February 25, 2000
Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and 40 concentrations in Alzheimer's diseaseT Tapiola, T Pirttilä, M Mikkonen, et al.
Pageof 121

Showing results (361-370 of 1,209) with videos related to

Sort By:
Pageof 121
Neuroreport|June 19, 1995
Hippocampal atrophy, acute THA treatment and memory in Alzheimer's diseaseP Riekkinen, H Soininen, E L Helkala, et al.
Mechanisms of Development|November 1, 1992
The mouse Enhancer trap locus 1 (Etl-1): a novel mammalian gene related to Drosophila and yeast transcriptional regulator genesR Soininen, M Schoor, U Henseling, et al.
Neuroscience|January 1, 1995
Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's diseaseO Heinonen, H Soininen, H Sorvari, et al.
Journal of Neurology|April 29, 2008
Genetic study between SIRT1, PPARD, PGC-1alpha genes and Alzheimer's diseaseS Helisalmi, S Vepsäläinen, M Hiltunen, et al.
Toxicology Letters|September 19, 2015
Human placental cell and tissue uptake of doxorubicin and its liposomal formulationsSuvi K Soininen, Jenni K Repo, Vesa Karttunen, et al.
Neuroscience|August 1, 1992
Slowing of electroencephalogram and choline acetyltransferase activity in post mortem frontal cortex in definite Alzheimer's diseaseH Soininen, K J Reinikainen, J Partanen, et al.
The European Journal of Neuroscience|April 14, 2004
Visual presentation of novel objects and new spatial arrangements of objects differentially activates the medial temporal lobe subareas in humansMaija Pihlajamäki, Heikki Tanila, Mervi Könönen, et al.
Neuroscience Letters|May 6, 2008
Increased expression of Abeta degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathologySaila Vepsäläinen, Mikko Hiltunen, Seppo Helisalmi, et al.
Diabetes Care|January 24, 2013
History of medically treated diabetes and risk of Alzheimer disease in a nationwide case-control studyAnna-Maija Tolppanen, Piia Lavikainen, Alina Solomon, et al.
Neuroscience Letters|February 25, 2000
Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and 40 concentrations in Alzheimer's diseaseT Tapiola, T Pirttilä, M Mikkonen, et al.
Pageof 121